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La mort subite d'origine cardiaque chez les sportifs: les Recommandations de Lausanne 
Résumé 
Objectifs: 
Cette étude collecte les données de la littérature scientifique concernant la mort subite 
d'origine cardiaque chez les sportifs et a pour but d'aboutir à un protocole d'investigation de 
préparticipation globalement acceptable, approuvé par la conférence de consensus du Comité 
International Olympique( CIO), et recommandé par ce dernier. 
Données cliniques : 
La mort subite chez les athlètes de moins de 35 ans, engagés dans des sports de compétition, 
est un évènement bien connu, dont l'incidence est plus élevée (~21100000/an) que chez les 
non-athlètes (2,5 : 1 ). La cause est cardiovasculaire dans plus de 90% des cas. 
Méthodes: 
Une revue systématique de la littérature a mis en évidence les causes de mort subite d'origine 
cardiaque, le sexe, l'âge, les maladies cardiaques sous-jacentes et le type de sport, ainsi que 
les protocoles d'investigation de préparticipation utilisés. Les méthodes nécessaires pour 
détecter des anomalies cardiaques préexistantes sont discutées pour formuler un protocole 
d'investigation de préparticipation pour la commission médicale du CIO. 
(http://www.olympic.org/uk/organisation/commissions/medical/full story uk.asp?id=l 182) 
Résultats: 
1101 cas de mort subite d'origine cardiaque ont été rapportés (1966-2004) chez des athlètes 
de moins de 35 ans, 50% présentant des anomalies cardiaques congénitales et des 
cardiomyopathies et 10% une athérosclérose à début précoce. 40% des athlètes avaient moins 
de 18 ans, 33% moins de 16 ans; le rapport femme/homme était de 1/9. La mort subite 
d'origine cardiaque était reportée dans presque tous les sports; ceux impliqués le plus 
fréquemment étaient le football(30%), le basketball(25%), et la course à pied(l5%). Les tests 
de préparticipation étaient de quàlité èt de contenu variables. 
La conférence de consensus du CIO a accepté les «Recommandations de Lausanne » 
proposées, basées sur cette recherche et des opinions d'experts. 
(http://multimedia.olympic.org/pdf/en report 886.pdt) 
Conclusions: 
La mmi subite d'origine cardiaque touche plus souvent qu'attendu les jeunes athlètes et est 
principalement due à des anomalies cardiaques congénitales préexistantes. Les atteintes 
athérosclérotiques précoces forment une autre cause importante de décès chez les jeunes 
adultes. L'acceptation par le CIO de« Recommandations de Lausanne» a permis d'aboutir à 
un protocole d'investigation de préparticipation globalement acceptable. 
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Objectives This study reports on sudden cardiac death (SCD) in sport in the literature and aims at achieving a generally 
acceptable preparticipation screening protocol (PPSP) endorsed by the consensus meeting of the International Olympie 
Committee (IOC). 
Background The sudden death of athletes under 35 years engaged in competitive sports is a well-known occurrence; the 
incidence is higher in athletes ( ~ 2/1OO000 per year) than in non-athletes (2.5: 1 ), and the cause is cardiovascular in over 
90%. 
Methods A systematic review of the literature identified causes of SCD, sex, age, underlying cardiac disease and the type 
of sport and PPSP in use. Methods necessary to detect pre-existing cardiac abnormalities are discussed to formulate a 
PPSP for the Medical Commission of the IOC. 
Results SCD occurred in 1101 (1966-2004) reported cases in athletes under 35 years, 50% had congenital anatomical 
heart disease and cardiomyopathies and 10% had early-onset atherosclerotic heart disease. Forty percent occurred in 
athletes un der 18 years, 33% under 16 years; the female/male ratio was 1 /9. SCD was reported in almost ail sports; most 
frequently involved were soccer (30%), basketball (25%) and running (15%). The PPSP were of varying quality and content. 
The IOC consensus meeting accepted the proposed Lausanne Recommendations based on this research and expert 
opinions (http://multimedia.olympic.org/pdf/en_report_886.pdf). 
Conclusion SCD occurs more frequently in young athletes, even those under the age of 18 years, than expected and is 
predominantly caused by pre-existing congenital cardiac abnormalities. Premature atherosclerotic disease forms another 
important cause in these young adults. A generally acceptable PPSP has been achieved by the IOC's acceptance of the 
Lausanne Recommendations. Eur J Cardiovasc Prev Rehabil 13:000-000 © 2006 The European Society of Cardiology 
European Journal of Cardiovascular Prevention and Rehabilitation 2006, 13:000-000 
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Introduction 
Active participation in sports is generally considered to be 
beneficial for the health and well being of the individual 
[ 1]. The increased risk of sudden death in adolescents 
and young adults engaged in competitive sports, a well-
known and much feared occurrence, seems to contradict 
this adagium [2-4]. The leading cause of this mortality is 
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underlying cardiac disease (~90%) [5-7], triggering 
sudden death during intensive physical exercise. The 
non-cardiac causes of sudden death include asthma 
(or other pulmonary conditions), heat stroke, drug abuse, 
cerebral embolism, ruptured cerebral artery and some 
unexplained causes. 
The incidence of sudden cardiac death (SCD) in young 
athletes (aged 12-35 years) is 0.5-2/100 000 per year 
[4,6,8-10], and is approximately 2.5 rimes higher than in 
non-athletes [ 11]. This increased mortality has led to the 
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implementation of various preparticipation screening 
protocols (PPSP), showing a wide difference depending 
on the mandating organizations or countries. Sorne are 
quite specific and involve serious physical examinations, 
whereas others are merely questionnaires. The quality of 
each of these PPSP depends greatly on the way the 
examinations are carried out, and varies from inadequate 
to thorough. 
A generally accepted and implemented PPSP would be 
preferable, but the difficulty in achieving a consensus is 
located in the vast number of governing bodies involved. 
Severa! governments have by law implemented different 
regulations, various sports organizations have started to 
use their own PPSP, and a diversity of medical organiza-
tions have issued, sometimes very different, guidelines. 
The aim of our review of the literature was to analyse the 
reported cases of SCD among young athletes, to identify 
the sports with the highest risk of SCD, and to compare 
the PPSP in use. 
This was to allow an evaluation of the effect of the 
different methods and to assemble the parameters 
required to propose to the International Olympie Com-
mittee (IOC) a generally acceptable and safe screening. 
Methods 
For a meta-analysis of the existing literature on sudden 
death in sports and the effectiveness of PPSP, the 
following databases were searched: Medline (OVID Web, 
1966-2004), PubMed (1966-2004), Cochrane Database 
of Systematic Reviews, EBM Reviews - ACP Journal 
Club, Cinahl 1982-2004, Heracles, Web of Science, 
Scopus < 1960-2004. We used 'sudden cardiac death' 
and 'preparticipation' as keywords, combined with 
'sports', 'sports medicine', 'athletic injuries', 'exercise' 
and 'athletes'. Restrictions were English language and 
human subjects. To be overinclusive, there were no 
restrictions concerning age, sex, or study methodology. 
The keyword search yielded MeSH headings, which were 
exploded before they were combined. For study and data 
selection, we reviewed the results of the search and 
selected and grouped ail studies reporting on SCD 
(reported cases) and the use of PPSP. Sudden death in 
athletes by other causes such as neurovascular, heat and 
doping were excluded and will not be discussed. 
The initial search identified 2866 articles (SCD 1493 
plus PPSP 1532) after duplicates were removed. 
Sudden cardiac death 
A total of 1493 articles were identified by the initial 
search; 124 were relevant to SCD in athletes, and were 
available, after review of ail the titles and abstracts. We 
focused on athletes under 35 years of age, as the causes of 
SCD change past 35 years, atherosclerotic coronary artery 
diseases becoming much more frequent (84 versus 2% 
before 35 years) [5,12-18]. Content experts within the 
medical profession were contacted as well as the relevant 
sports organizations to identify studies missed by 
electronic searches. 
We used the following criteria to select the articles 
relevant to our study: articles reporting cases of SCD in 
athletes, aged up to 35 years, exercise-related, and in the 
absence of evidence of drug abuse. 
SCD is defined as a death occurring within 1 h of the 
onset of symptoms in a persan without a previously 
recognized cardiovascular condition that would appear 
fatal. An athlete is defined as a persan participating in an 
organized team or individual sport that requires systema-
tic training and regular competition against others, and 
that places a high premium on athletic excellence and 
achievement [ 19,20]. 
There were 4 7 articles left after this final selection 
(Table 1), which we analysed. 
Preparticipation screening protocols 
A total of 1532 articles were identified by the initial 
search; 108 were relevant to PPSP in athletes, and were 
available, after review of ail the titles and abstracts. 
Content experts within the medical profession were 
contacted as well as the relevant sports organizations to 
identify studies missed by electronic searches. 
We used the following criteria to select and group the 
articles relevant to our study: (i) articles describing 
the PPSP procedure (cardiovascular part) and using it 
(± reported cases; Table 2); (ii) articles describing the 
PPSP procedure (cardiovascular part) but not using it 
(no reported cases; Table 3); (iii) articles about PPSP, 
specifically electrocardiography (ECG) or echocardiography 
[ 41,43,45,46,48,50-53]. Thirty-one articles were selected, 
with 11 in (i), 11 in (ii), and nine in (iii), and were analysed. 
These groupings were reviewed and approved by an ad 
hoc consensus meeting of the IOC working group on 
Sudden Death in Athletes including several authors of 
the primary studies included and the Medical and 
Scientific Director of the IOC Medical Commission. 
Outcomes of the studies were summarized for strength of 
evidence. The definitions of outcome of the authors of 
the studies included were accepted. 
Results 
Sudden cardiac death 
Forty-seven articles were analysed and are represented 
in Table 1. The references of the articles were noted 
Table 1 Selected articles on sudden cardiac death (SCD) 
Authors/journal Type of article/study No. of cases Sex (m, male; Previous symptoms Clinical data Autopsy Cardiovascular diagnosis 
ofSCD f,female) 
[21] Bassa, JACC 2000 Review 27 22 m/5 f Yesin10 Yes in 12 27 27 AOCA 
[22] Bharati, JACC 1983 Case reports 3 2 m/1f ? Yes 3 1 MVP 
3 Sclerosis of ventricular septum with involvement 
of conduction system 
[23] Biffi, JACC 2002 Prospective 1 m ? Yes ? 1 ARVD 
[24] Burke, JACC 1993 27 17 m/10 f Yes in 4 ? 27 27 Presumed cardiac arrhy1hmias by non-athero-
sclerotic narrowing of the AV node artery 
[25] Burke, Am Heart J 1991 34 31 m/3 f ? ? 30 9 Severe atherosclerosis 
8 HCM 
3 Idiopathie LV hypertrophy 
4 Anomalous coronary artery 
2 Myocarditis 
1 RV dysplasia 
1 Kawasaki 
6 Unknown (2 tunnel arteries) 
[26] Cheitlin, Circulation 1974 9+1 9m+1m ?+yes ? 9 ( + 1 aborted SCD) 9+1 AOCA 
[27] Corrado, Circulation Prospective 31 24 m/7 f Yes ïn some ? 31 31 ARVD 
2001 
[28] Corrado, Am J Med 1990 Post-mortem 22 19 m/3 f Yes in 9 Yes in some 22 6 ARVD 
4 Atherosclerotic CAD 
3 Conduction system pathology 
2AOCA 
2 MVP 
2 Mechanical causes 
3 Cerebral causes 
[11] Corrado, JACC 2003 Prospective 55 50 m/5 f Yes in 18 Yes in some 55 12 ARVD 
1 0 Atherosclerotic CAD 
7 AOCA 
6 MVP 
5 Myocarditis 
4 Conduction system pathology 
2 Myocardial bridge 
1 HCM 
1 DCM 
1 LOTS (/) c: 
2 Mechanical causes c.. c.. 
7 Non-cardiovascular causes CD 
[29] Corrado, Br Heart J 1992 Postmortem 12 8 m/4 f Yes in 6 Yes in some 12 3AOCA :::l n 
5 lntramyocardial course of LADCA Dl a. 1 lntramyocardial course of LMCA iiï 
1 SliHike lumen of left coronary ostium n 
2 Valve-Jike ridge of right coronary oslium c.. CD 
[30] Corrado, NEJM 1998 Prospective 49 44 m/5 f Yes in 14 Yes in some 49 11 ARVD Dl 
Cf. study9 
:;: 
9 Coronary atherosclerosis :ï 
6AOCA S. 
::l" 
5MVP ëD 
4 Disease of conduction system CD" 
3 Myocarditis "' ~ 2 Myocardial bridge èD 
1 DCM ~ 1 HCM 
'" 2 Mechanica/ causes :--
5 Other 
"' 
Table 1 (continued) -!>-
Type of article/study No. of cases Sex (m, male; Previous symptoms Clinical data Autopsy Cardiovascular diagnosis m Authors/journal c: 
of SCD f, female) a 
"tl (!) 
[31] Dead~, J Emerg Med Case report No ? 1 Commotio cordis "" 1 m ::::i
1999 ê5" 
[32] Fomes, Am J Forens Med 19 18 m/1 f No ? 19 4ARVD c: 3 Pathol 2003 !!!. 
4 HCM ~ 3 CAD (1 +thrombosis) (") 
2 Bridging of LADCA 
"" 2 Myocarditis (1 chronic + 1 acute) a. 
ëï 1 Anatomical anomaly of CA < 
3 Mechanical cause (rupture of aortic aneurysm) "" (J) [33] Goldschmidt, Lance! Case report 1 m No Yes 1 CAD 0 c: 
1996 ~ 
[34] Hoogsteen, Netherlands Case reports 2 2m Yes in 1 Yes 2 2 ARVD ""C 
Heart J 2004 Cil 
< [35] lskandar, Med Sei Sports Case report 1 m Yes Yes 1 Coronary artery anomaly (!) 
Exerc 2004 ::!. ëï [36] Jokl, JAMA 1970 Case reports 2 2m ? ? 2 1 AOCA with underdevelopment of the entire ::::i 
arterial system 
"" ::::i 
1 Subacute myocarditis a. 
[37] Khoury, Eur Heart J 1994 Case report 1 m ? ? No (aborted SCD) ::0 (!) 
[38] Kramer, Chest 1988 Retrospective 24 ? Yes in some Yes in some 24 7 Myocarditis ;;r" 
"" 6 HCM g 
3 lschaemic heart disease ~ 3 MVP 
2 Marfan's syndrome ë" ::::i 
1 Congestive cardiomyopathy 
"" 1 Conduction abnormality 0 
1 AOCA 0 9' [39] Larsson, APM!S 1999 Retrospective 16 15 m/1 f Yes in 5 Yes in most 16 7 Myocarditis < Cf study by Wess/en Q. 
4 ARVD or ARVD-like (,) 
3 Fibrosis + hypertrophy z 
1 Fibrosis, fatty infiltration 0 
1 WPW syndrome 0 0 [40] Lesauskaite, Am J For- Case report 2 cases 2 male 20 and 22 Yes Yes Yes 2 Hypop/astic CAO myocardial hypoperfusion 
ensic Med Patho/ 1998 years 
[42] Link, Chest 1998 Case report 1 m No Yes after event No (aborted SCD) 1 commotio cordis 
[44] Maron, JACC 2003 18 Competitive 286 256 m/30 f Yes"in55 Yes in 252 286 102 HCM 
sports 
192 cases 
basketball or 37 AOCA 
football 29 lndeterminant, possibly HCM 
20 Myocarditis 
12 Ruptured aortic aneurysm 
11 ARVC 
11 T unnelled coronary artery 
1 0 Aortic valve stenosis 
1 0 Atherosclerotic CAD 
9 Idiopathie DCM 
9 MVP 
8 Coronary artery hypoplasia 
8 Other congenital anomalies 
3 Cardiac sarcoidosis 
3 LOTS 
3 Congenital heart disease 
1 Myocardial infarction 
[8] Maron, JACC 1998 Retrospective 3 3m No Yes 3 1 AOCA 
1 Congenital aortic valve stenosis (bicuspid) 
1 Myocarditis 
[47] Maron, JAMA 2002 Retrospective 128 cases l 107 122 m/6 f ? ? Yes in 82 79 Commotio cordis 
fatal 
(49] Maron, NEJM 1995 Retrospective 25 24 m/1 f ? ? 22 1 6 Commotio cordis 
[12] Maron, JACC 1996 Retrospective 2 1iîi71T No Yes 2 1 Anomalous LMCA 
1 Atherosclerotic CAO 
[2] Maron, Circulation 1980 Prospective and 29 26 m/3 f Yes in 8 Yes in 7 29 14HCM 
retrospective 
4AOCA 
5 Idiopathie concentric LV hypertrophy 
3 Coronary heart disease 
2 Ruptured aorta 
1 Unknown 
[3] Maron, JAMA 1996 Retrospective 134 SCD (+7 120 m/14 f Yes in 24 Yes in 115 Yes 48 HCM 
commotio cordis) 14 Unexplained increase in cardiac mass (HCM?) 
17 Aberrant coronary arteries 
8 Other coronary anomalies 
6 Ruptured aortic aneurysm 
6 Tunnelled LADCA 
5 Aortic valve stenosis 
4 Lesion consistent with myocarditis 
4 Idiopathie dilated cardiomyopathy 
4ARVD 
4 Idiopathie myocardial scarring 
3 MVP 
3 Atherosclerotic CAO 
2 Other congenital heart syndrome 
1 Long QT syndrome 
1 Sarcoidosis 
1 Sickle cell trait 
3 'Normal' heart 
(54] Menke, Chest 1985 Case report 1 m No Yes 1 Hyoplastic coronary arteries and high takeoff 
position of the right coronary ostium 
en [56] Morentin, Arch Dis Child Population-based 10 9 m/1 f Yes in some Yes in some 10 3 Arrhythmogenic cardiomyopathy c: 
2000 observational study a. a. 
2 HCM Cil :J 
1 DCM 0 
1 Myocarditis "' a. 
1 AOCA Eï 
1 Tetralogy of Fallot 0 
a. 1 WPW syndrome Cil 
"' (58] Nilsson, Lance\ 1999 Case studies 2 2m Yes Yes 2 2 Myocarditis 5' [9] Phillips, JAMA 1986 Retrospective 19 19 m ? ? 19 8 Myocarditis :; 
3 Coronary anomalies S. 2 HCM ;;;,-
Floppy mitral valve m 
Shone's syndrome (parachute mitral valve and (t en 
subaortic stenosis) + sickle cell trait ~ Focal subendocardial fibrosis and calcification ro 
with normal coronary arteries ~ 
3 No aetiological DX 
"' :--
01 
Table 1 (continued) Ol 
Authors/journaJ Type of article/study No. of cases Sex (m, male; Previous symptoms Clinical data Autopsy Cardiovascular diagnosis m c: 
of SCD f, female) ël 
"O 
(1) 
"' [15] Quigley, JAMA 1986 Retrospective study 51 t11<35y 50 m/1 f Yes in some ? 11 3 Atherosclerotic GAD :::1 
2 Aortic stenosis 0 
1 HCM c: :; 
1 Congenital coronary artery anomaly !!!. 
1 Cardiac arrhythmia a 
1 Multiple areas of fibrosis on myocardium 0 
2 Non-cardiac 
"' [61] Rozin, Am J Forens Med Retrospective 1 m No ? 1 Kawasaki disease a. 5· 
Pathol 2003 review < 
[62] Schionning, Am J Forens Retrospective 2 m/1 f Yes in one Yes in 2 3 ARVD "' 3 3 Ul (') 
Med Pathol 1997 c: 
[63] Scoville, Am J Prev Med Population-based 59 ? ? ? 59 27 Coronary artery abnormality ~ 
2004 review -c 
12 Myocarditis êD < 
5 Cardiomyopathy (1) ~ 6 Atherosclerotic cardiovascular disease 5· 
3 Conduction system abnormality :::1 
3 Cardiac valvular disease 
"' :::1 
2 Myocardial fibrosis a. 
1 Ephedrine-induced arrhythmia ;o (1) 
[64] Tabib, Circulation 2003 Retrospective 7 3 m/4 f ? ? 7 7 ARVD ::r 
"' [66] Tabib, Eur Heart J 1999 Retrospective 80 77 m/3 f No ? 80 27 Atherosclerotic GAD (1 <30 y) g; 
19 HCM ~ 9 DCM 5· 
8 ARVD :::1 
5 His bundle structural anomalies 
"" 2 Scarred myocardial bruising 0 0 2 Muscular bridging in LADCA 
-°' 2 Congenital aortic bicuspid stenosis < 
1 Aneurysm (Kawasaki disease) 2-
1 Asymmetric HCM c,:, 
1 Tawarien mesothelioma z 
1 Marian disease 0 
1 MVP + IAC + fibrosis of His bundle trunk 0 0 
[55] Taylor, J Am Coll Cardial Retrospective 242 autopsies L 34 201 m/41 f Yes in some ? 34 18 LMCA and RCA from R Ao sinus 
1992 cardiac and 
exercise-related 
6 RCA and LMCA from L Ao sinus 
3 Hypoplastic CA 
2 LMCA or LAD from pulmonary trunk 
2 RCA and/or LMCA from posterior Ao sinus 
2 Single RCA ostium from aorta 
1 Single LCA ostium from aorta 
[69] Tecce, Catheterization Case report 1 m No ? No (aborted SCD) 1 Spasm of left anterior descending artery 
and Cardiovasc Diagnosis 
1994 
[71] Thakore, J Accid Emerg Case reports 2 2m No ? 2 Commotio cordis 
Med 2000 
[73] Trusty, AACN Clinical Case report 1 m No Yes No (aborted SCD) 1 HCM 
issues 2004 
[75] Warren, West J Med Case report 1 f Yes Yes 1 Familial cardiomyopathy (HCM?) 
1979 
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(classified in alphabetical order according to the last 
name of the first author), the type of article, the number 
of reported cases, the age and sex of the cases, the 
activity when SCD occurred, the eventual presence of 
previous symptoms and clinical data, whether an autopsy 
was carried out, and finally the cardiovascular diagnosis. 
The articles were either case reports, relating the death 
of one or several athletes, or larger retrospective, some-
times prospective, studies. They were published between 
1970 and 2004. The total of reported cases of SCD in 
athletes is 1101 cases (articles reporting the same cases 
are excluded, and appear in italics). This total includes 
the 103 cases of commotio cordis (blunt trauma to the 
chest, not particularly violent, that causes arrhythmias 
potentially followed by death) found in the articles 
( underlined). 
The 1101 cases were grouped after pathology, according 
to the cardiovascular diagnosis, into 10 groups and 31 
subgroups, as shown in Table 4. Coronary artery 
anomalies, half of them being anomalies of the origin of 
the coronary artery, the other half anomalies of the course 
of the coronary artery, and hypertrophie cardiomyopathy 
(HCM) are the two largest groups, with 262 and 261 
cases, respectively. Traumatic cases of SCD being 
excluded (103 cases), there are 998 remaining cases, as 
shown in Fig. 1. 
Focusing on the youngest athletes, 80 out of 199 were 
under 18 years of age, which represents as muchas 40% of 
the cases, and 6 7 were under 16 years, 20% of the cases, 
with ail types of underlying cardiac pathologies. 
The cases were also grouped according to the sports the 
athletes were engaged in when sudden death occurred 
(Fig. 2). In 388 cases the sport practised when SCD 
occurred was mentioned. Deaths by commotio cordis 
(103) are not included in this figure. 
Preparticipation screening protocols 
A total of 108 articles were considered, and 31 articles 
were examined more closely, separated into three groups. 
(i) Articles describing the PPSP procedure ( cardiovas-
cular part) and using it (± reported cases): 11 articles. 
The articles were classified in Table 2, by alphabetical 
order of the first author. We looked at the population 
screened, where the PPSP was produced and when, who 
was performing the PPSP, at what frequency, what was 
the content of the PPSP (medical history, physical 
examination, non-invasive tests), the number of athletes 
screened, the number of athletes disqualified by the 
PPSP and the number of SCDs. (ii) Articles defining the 
PPSP procedure (cardiovascular part) but not using it; no 
reported cases: 11 articles. The articles were classified in 
Table 3, by alphabetical order of the first author. We 
Table 2 Articles describing the preparticipation screening protocols procedure (PSPP) and using it to 
Authors Population screened Origin of Persans performing PPSP Frequency of Content No. of athletes No. of athletes No. ofSCD m c: 
protocol screening screened disqualified a 
'tl 
(!) 
[68] Bader, 2004 School grades 7-12 USA 2001 Healthcare professionals Every 2 years MH 
"' ::; 
PhE (5" 
NITa c: 
[81] Brukner, 2004 Athletes <35 years Australia Doctors On admission+ MH :; 
regular basis ~ 
PhE S. 
Nil" (") 
"' [82] Cantwell, 1998 Athletes USA Doctor ? MH a. 
PhE ë" 
< 
Nil" 
"' (J) [30]·Corrado, 1998 Athletes<35 years ltaly ? ? MH 33735 1058: CV cause: 269 SD, 49 in 0 c: (prospective study) 621 1 SD campe!. athletes ~ 
PhE 
-0 
NIT <n 
3016 Echo < (!) 
[70] Fuller, 1997 High school: 13-19 years USA MH, BP, ECG by cardiac technician ? MH 5615 22 1 Aborted SCD :a. 
(prospective study) Cardiologists ë" ::; 
PhE 
"' NIT 582 Echo ::; o. 
[72] Glover, 1998 High school, grades 9-12 USA 21/51 Others !han physicians OK ? MH ;o 
PhE (!) :::r 
[74] Koester, 2003 High school USA 72/154 OK by nurse practitioner ? MH "' [ 39/154 OK by physician assistant PhE ~ 221154 OK by chiropractors 
12/154 OK by naturopathie clinicians ë" ::; 
[83] Maron, 1987 College: 17-30 years USA 3 Clinicians member of Health Center Annual MH 501 Athletes 0 
(prospective screening) staff ~ 0 
PhE 0 
NIT 90 Echo 
_m 
[76] Pfister, 2000 College USA Team physician 6031713 (451 Annual in 446/879 MH ~ 
orthoped surg, 149 internai med, 
32 pediatr) Ü) 
135 OK by nurse practitioners On college entry in PhE z 0 
433/879 0 
2441713 OK by athletic trainers NIT in 58 0 
[78] Smith, 1998 High school USA Physicians and residents + therapists, Every 3 years MH 2739 Athletes 53 (10 for cardiac 
dietitians, secretariesf nurse counsellor reasons) 
in sports psychology 
Final decision by physician PhE + 1 7 cases with CV 
anomalies where fol-
low-up was recom-
mended 
UCI, 2003 Cyclists Switzerland Team doctor 6 Months-2 years MH 1 4 Cyclists with life- 14 1 SCD (ARVD) 
+in case of symp- threatening CV pro- before disqual. 
toms blems (21-35 years) 
PhE 
NIT ( echo and stress 7 SCD alter disqual. 
ECG every other 
year) 
ARVD, Arrhythmogenic right ventricular dysplasia; BP, blood pressure; CV, cardiovascular; ECG, electrocardiogram; MH, medical history; NIT, non-invasive tests; PhE, physical examination; SCD, sudden cardiac death; SD, 
sudden death. "Not routine. 
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Table 3 Articles describing a preparticipation screening protocols procedure, without using it 
Authors Origin of protocol, year when Persans performing PPSP Frequency of screening Content 
introduced 
[79] Armsey, 2004 Athletes high school and college Sports medicine team (PPSP stations) Every 3-4 years (some places MH 
(USA) every year): full PPSP screening 
Athletic training staff Yearly: medical history PhE 
Team orthopaedists Further testing no! 
discussed 
Team medical staff (medical exam, 
orthopaedic assessment and checkout 
by physician) 
[84] Beckermann, Athletes high school and college ? AHA 1996 recommends: every 2 MH 
2004 Stanford CA (USA) years for young athletes + annual 
BP for college athletes 
PhE 
NIT 
[85] Drezner, 2000 Athletes high school and college ? AHA 1996 recommends: for high MH 
(USA) school athletes every 2 years 
+ interim history in intervening 
years. For collage athletes, 
history and BP every year 
PhE 
NIT" 
[86] Glorioso, 2002 AHA recommendations +Marian ? ? MH 
screening 
PhE 
NIT 
[87] Gomez, 1999 Survey of 500 US high schools-> ? ? MH Further testing 
254 responses. Recommanda- not discussed 
tians from the American Acad-
emy of Pediatrics. 
[88] Kurowski, 2000 Preparticipation athletic evaluation, ? ? MH 
Illinois (USA) 
PhE 
NIT" 
[89] Lyznicki, 2000 CV screening of student athletes. Trained healthcare worker, preferably For high school athletes, every MH 
AHA recommandations (18) a physician (AMA recommends only 2 years with an interim history 
PPSP Task Force (18) licensed physicians) in intervening years 
PhE 
NIT" 
[90] Maron, 1996 AHA scientific statement (USA) Healthcare worker with requisite training. Before participation then every MH 
( + 1998 addendum) 1996. High school and collegiate Preferably a licensed physician 2 years. lnterim history in 
athletes intervening years + BP 
PhE 
NIT" 
[91] Metzl, 2001 PPSP of the adolescent (USA) Physician ? MH 
(NB: no! focused on CV system) 
PhE Refer Io 
cardiologist for further 
investigations 
[92] O'Connor, 1998 AHA recommandations (American ? Before participation then every 2 MH 
Academy of Family Physicians) years. lnterim history in interven-
ing years 
PhE Refer to cardiale-
gis! for further 
investigations 
[93] Soni, 1997 Children Physician To be reviewed on an ongoing basis MH 
PhE 
NIT ("by specialist) 
AHA, American Heart Association; AMA, American Medical Association; BP, blood pressure; MH, medical history; NIT, non-invasive tests; PPSP, preparticipation 
screening protocol; PhE, physical examination. "Not routine. 
looked at the ongm of the protocol, the persans 
performing the PPSP, the frequency of screening and 
the content of the protocol. (iii) Articles about PPSP, 
specifically ECG or echocardiography: nine articles 
[41,43,45,46,48,50-53]. We focused on the utility of the 
test for diagnosing underlying cardiovascular diseases, the 
indications for using the test, the cost-effectiveness, and 
the opinion of the author on the test. 
Discussion 
Physical activity is promoted and encouraged in society. It 
is considered healthy, with positive effects on the body 
and the mind. Healthcare and educational systems incite 
the population to be active in sports. The increased risk 
of exercise-related sudden death [10,55,57] might pose 
an irrelevant question mark on this statement, which is 
not justified because the positive effects of regular 
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Table 4 Causes of sudden cardiac death 
Pathology No. of Pathology subgroups No. of 
groups cases cases 
Congenital 326 Coronary artery anomalies: 262 
Origin (L>R) 125 
Course (L> R) 124 
Spasm (LCA) 1 
Hypoplasia 12 
Cardiac valve diseases: 50 
Mitral valve prolapse 27 
Aortic valve stenosis 20 
Unspecified 3 
Shone's syndrome 1 
Cardiomyopathies 309 Hypertrophie cardiomyopathy 261 
Dilated cardiomyopathy 24 
Unspecified 12 
Myocardial scarring 6 
Sickle cell trait 1 
Fibrosis + fatty infiltration 5 
Unspecified 13 
Arrhythmia 126 Arrhythmogenic right ventricular 97 
cardiopathy/dysplasia 
Long OT syndrome 5 
Conduction system pathology 20 
Wolf-Parkinson-White 1 
syndrome 
Anatomical basis for 
preexcitation 
Ephedrine·induced arrhythmia 1 
Unspecified 1 
Atherosclerotic 112 Atherosclerotic coronary artery 112 
disease 
Trauma 103 Commotio cordis 103 
lnfectious 78 Myocarditis 78 
Degenerative 31 Cardiac sarcoidosis 4 
Marfan's syndrome 4 
Ruptured aorta (aneurysm) 23 
Undetermined 10 10 
Acquired 3 Kawasaki 3 
'Normal heart' 3 3 
Total 1101 1101 
L, Left; LCA, left coronary artery; R, right. 
physical act1v1ty far outweigh the negative effects. 
Exercise-related sudden death can have many causes, 
such as cardiac, asthma or other pulmonary conditions, 
heat stroke (hyperthermia and dehydration), cerebral 
embolism or ruptured cerebral artery, trauma of the spine 
or head, drug abuse and doping. Doping is often 
considered to be the main cause of sudden death by 
the media and Jay people [ 59], which seems unlikely, as 
underlying cardiac diseases account for approximately 
90% of exercise-related sudden deaths [5-7]. 
The incidence of SCD in young athletes is 0.5-2/100 000 
per year [6,8-10]. Although the underlying forms of 
cardiac pathology are infrequent, they are represented in 
the athletic population as they are in the general 
population. The intense physical training and competi-
tion, with the accompanying higher cardiovascular 
demands, enhances the risk of athletes suffering serious 
consequences from their underlying cardiovascular dis-
ease [2,3]. The identification of the pre-existing pathol-
ogy suggests that sport i tself is not perse the cause of the 
increased mortality; it rather acts as a trigger upon 
Fig. 1 
80/o 30/o 
31% 
Causes of sudden cardiac death. O, Congenital anatomical; 11!1, 
cardiomyopathies; D, arrhythmias; D, atherosclerotic; lllil, infectious; 
O, degenerative; O, undetermined; O, acquired; li!ll, 'normal heart'. 
underlying cardiovascular diseases, predisposing to life-
threatening ventricular arrhythmias during physical 
exercise. 
The unfortunate absence of national or international 
registers, which could provide precise data, suggests that 
SCD, although the present numbers are already impress-
ive, is probably under-reported. The absence of precise 
data makes our/any analyses of reasons for SCD fragile 
and probably biased. For example, coronary artery 
diseases and HCM are the leading causes of SCD but 
are also the easiest to find; more difficult to find causes 
such as arrhythmias and arrhythmogenic right ventricular 
dysplasia may be under-represented. Cardiac causes of 
sudden death in the cases reported are listed in Table 4. 
Congenital coronary anomalies, such as abnormal origin 
and abnormal course of the coronary arteries and HCM 
are the leading causes of SCD [3,4,6,7,17-19,60]. The 
reported leading causes of SCD, however, vary greatly 
from author to author. Corrado et al. [11] reported 
coronary artery anomalies (atherosclerotic and non-
atherosclerotic) as by far the leading group with 30% of 
cases, whereas HCM accounts for only 7% [27,29,30]. 
Hoogsteen et al. [ 34] reported 38% of cases caused by 
HCM, with 26% of coronary artery anomalies. 
The low proportion of SCD with a normal heart at 
pathological examination is another point of interest, 
which probably has to do with the interest of the 
pathologist or cardiologist to report on clearcut pathology 
rather than normal conditions, together with the fact that 
in our study we excluded ail potential doping-related 
events. 
A remarkable point is that atherosclerotic coronary artery 
disease already plays an important role in SCD in the 
young athlete; this premature form of atherosclerosis 
accounts for 2-20% of the cases of SCD depending on the 
study, and has long been overlooked. 
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Number of cases of sudden cardiac death (SCD) by sport. 
Table 5 Classification of sports 
Examples 
Low isometrie 
Moderate isometrîc 
High isometric 
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Congenital anatomical heart diseases, cardiomyopathies 
and atherosclerosis represent 75% of the cases of SCD 
reported, if traumatic causes (commotio cordis) are 
excluded (Fig. 1). The various percentages of cardio-
pathie causes can be explained by the different 
incidences of the cardiopathies, HCM having an in-
cidence of only 1/500 [ 4,6,65,67], whereas anatomical 
anomalies of the coronary arteries have an incidence of 
0.3-1/100 [5,55]. 
A strikingly high percentage of very young athletes suffer 
from SCD. We found that approximately 40% of the total 
of SCD, in which the age wàs specified, occurred in 
athletes un der 18 years of age, 80 of 199 a thletes (out of 
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High isotonie 
Soeeer 
Basketball 
Cycling 
the total 998 cases), 67 of these were even younger than 
16 years. In the remaining 799 (998-80) the age was not 
specified. 
To assess the risk of SCD, sports can be classified 
depending on the dynamic (isotonie) and static (iso-
metric) work (Table 5). We grouped the reported cases 
by sport in Fig. 2, which shows that football/soccer, 
basketball and running/orienteering are the largest but 
not necessarily the most dangerous groups. They 
probably encompass the largest population of sports 
participants, because of their popularity. This does not 
mean that although these sports provide the largest 
number of SCD they necessarily are the sports with 
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Table 6 Lausanne Recommandations: sudden cardiovascular death in sport. Preparticipation cardiovascular screening. Under the umbrella 
of the International Olympie Committee Medical Commission, 10 December 2004 
Step 1: For ail participants 
Persona! history: Questionnaire by examining physician 
Have you ever fainted or passed out when exercising? 
Do you ever have chest tightness? 
Does running ever cause chest tightness? 
Have you ever had chest tightness, cough, wheezing, which made it difficult 
for you to perform in sports? 
Have you ever been treated/hospitalized for asthma? 
Have you ever had a seizure? 
Have you ever been told that you have epilepsy? 
Have you ever been told to give up sports because of health problems? 
Have you ever been told you have high blood pressure? 
Have you ever been told you have high cholesterol? 
Do you have trouble breathing or do you cough during or alter activity? 
Have you ever been dizzy during or alter exercise? 
Have you ever had chest pain during or alter exercise? 
Do you have or have you ever had racing of your heart or skipped heartbeats? 
Do you get tired more quickly than your friands do during exercise? 
Have you ever been told you have a heart murmur? 
Have you ever been told you have a heart arrhythmia? 
Do you have any other history of heart problems? 
Have you had a severe viral infection (for example myocarditis or mononucleosis) 
within the past month? 
Have you ever been told you had rheumatic lever? 
Do you have any allergies? 
Are you taking any medications at the present time? 
Have you routinely taken any medication in the pas! two years? 
Family history: Questionnaire by examining physician 
Has anyone in your family less than 50 years old: 
Died suddenly and unexpectedly? 
Been treated for recurrent fainting? 
Had unexplained seizure problems? 
Had unexplained drowning when swimming? 
Had unexplained car accident? 
Had heart transplantation? 
Had a pacemaker or defibrillator implanted? 
Been treated for irregular heart beat? 
Had heart surgery? 
Has anyone in your family experienced sudden infant death (col death)? 
Has anyone in your family been told they have Marian syndrome? 
Physical examination: 
General: 
Peripheral pulses 
Marian stigmata 
Cardiac auscultation: 
Rate/rhythm 
Murmur: systolic/diastolic 
Systolic click 
Blood pressure 
Diagnostic tests: 
12·1ead rest ECG: 
(alter the onset of puberty) 
Step 2: Selected cases with positive persona! history, family history of potentially 
inherited cardiac disease, or positive physical or ECG findings in Step 1 
require further evaluation by an age·appropriate cardiac specialist to qualify 
the athlete for sports participation 
Further evaluation may include transthoracic echocardiography, maximal exercise 
lasting, and 24·h ECG monitoring. ln addition, non-invasive screening of family 
members may provide valuable information about inherited cardiovascular 
disease 
Potentially detectable cardiovascular conditions 
Any cardiovascular condition 
lnherited cardiomyopathy (hypertrophie, 
arrhythmogenic RV, dilated) 
lnherited heart rhythm problem/cardiac ion 
channel diseases (long and short OT 
syndrome, Brugada syndrome, Lenègre 
disease, catecholaminergic polymorphie VT) 
Connective tissue disorders 
Coarctation of the aorta 
Aortic dilatation, mitral valve prolapse 
Ventricular ectopie beats 
Structural heart disease, outflow tract 
obstruction 
Aortic valve disease 
Hypertension 
Abnormal heart rate for age (unexplained sinus tachycardia or bradycardia) 
Abnormal heart rhythm 
PR/ORS: WPW 
Oîc/Twave: long or short OT syndrome 
T wave inversion/flattening: myopathy 
ECG, electrocardiogram; IOC, International Olympie Committee; RV, right ventricle; VT, ventricular tachycardia; WPW, Wolff-Parkinson-White syndrome. 
the highest risks. The sports with the highest cardio-
vascular demands and the highest isotonie work 
remain therefore to be more at risk of SCD, but because 
of a smaller number of participants have a smaller 
absolute number of SCD. This does not mean that 
the mentioned examples of sports perse represent a risk 
of SCD. 
After reviewing the causes of SCD and the sports with 
the highest risk of a cardiac event, the PPSP was 
considered. The studies reviewed reveal that the 
protocols are often considered as recommendations, and 
are only partly used. Sorne are considered inadequate for 
cardiovascular evaluation and contain four or fewer items 
recommended by the American Heart Association. The 
existing protocols ail include a medical history and a 
physical examination, in some cases diagnostic tests, of 
varying content. The persan performing the screening is 
also variable, some places allowing non-physicians 
[19,68,70,72,74,76,78,79,89,90] to conduct the examina-
tion, which decreases the chances of positive findings. 
One wonders what the results will be when technicians, 
nurses, chiropractors, or athletic trainers perform the 
cardiovascular screening. 
Even if a general consensus concerning the need for 
screening did exist, cost-effectiveness and the fact that it 
is not possible to prevent ail deaths constitute a major 
problem. The Italian screening programme, consisting of 
history, physical examination and ECG seems to be cost-
effective and efficient. Abnormal ECG lead to further 
investigations (often echocardiography) to detect cardi-
ovascular diseases at risk of sudden death in athletes. As 
only 9% are false positives, the low cost of the ECG 
justifies this small percentage of unnecessary echocardio-
graphies. As sport is a voluntary activity, death should not 
occur or at least be prevented as much as possible. 
Knowing the amount of money spent on top sports, the 
budget should also allow for the most efficient screening, 
to be performed by professionals. 
The articles studied in the PPSP parts (i) and (ii) show a 
striking lack of uniformity, considering bath quantity, the 
number of questions and tests, and quality. Although the 
protocols studied are aimed at detecting underlying 
cardiovascular diseases, in some the application of the 
recommendations is so limited that the usefulness of 
such screenings is questionable. The quality of the 
screening will not change its cost, as far as medical history 
and physical examination are concerned. 
When it cornes to the diagnostic tests, there are varying 
approaches, depending mostly on the population 
screened. Mass screenings in high schools and colleges 
most often do not comprise routine diagnostic tests, but 
in some places an ECG is included [30,70,83,84,93]. 
Suspect cases are referred to specialists for further 
investigations. In screening protocols for elite athletes, 
ECG and echocardiography at least are often routine 
[94]. This is the case for example in the programme of 
obligato1y examinations of the International Cycling 
Union. 
ECG and echocardiography each have their strong and 
weak points, and uniformity is,not reached here either. 
ECG can often be abnormal in well-trained athletes 
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[ 4,41,95-97], wi th patterns resembling th ose found in 
cardiovascular diseases such as HCM, which is the origin 
of many false positives. Despite this disadvantage, it is 
still considered a valuable screening tool because of its 
high negative predictive value and its low cost. Echo-
cardiography on the contrary is expensive, but can reveal 
the pathologies most frequently encountered in SCD. 
Our meta-analysis aims to provide a well furnished 
literature basis and form a platform for a generally 
accepted PPSP. The cooperation with the IOC and the 
consensus meeting on SCD in athletes organized by the 
Medical Commission of the IOC provided a tool to corne 
to a generally acceptable screening procedure adopted by 
the IOC as the Lausanne Recommendations. 
The Lausanne Recommendations (Table 6) are aimed at 
preventing SCD. We have assembled elements from the 
various existing protocols and studies that will help us 
best detect underlying cardiovascualr diseases that could 
cause SCD in athletes. It is a stepwise approach. 
Step 1 is the basic screening that should be offered to 
every athlete. It is focused on detecting underlying 
cardiovascular diseases and includes a detailed persona! 
history, a family history, a physical examination and a 12-
lead ECG. The questionnaire consists of preconceived 
closed questions, in which a 'yes-no' answer has to be 
given. Any 'yes' requires further enquiry. The family 
history is focused on cardiovascular diseases, either 
congenital or acquired, and premature sudden death. It 
is important that the physician performing the screening 
is trained to focus on the possible cardiac problems of 
intense sport, and that he/she can read the 12-lead ECG. 
Step 2 follows step 1 in case of positive findings in the 
medical history (persona! or family history) or in the 
diagnostic tests of the first step. These further evalua-
tions and investigations are the concern of a cardiologist. 
The tests in step 2 are chosen according to the type of 
positive finding. 
These Recommendations should be offered to the 
athletes with an explanation of the tests performed and 
the results that can be expected, and it should be clear 
that it is a voluntary participation for the athlete. 
Therefore his/her participation in the screening should 
be preceded by the signing of a form stating the written 
and informed consent and his/her right not to know 
should be respected in the case of refusai. Most recently, 
shortly after the acceptance of the Lausanne Recom-
mendations, bath the European Society of Cardiology 
[98] and the American Heart Association [99,100] 
published their recommendations. The European Society 
of Cardiology report recommendations coïncide with 
the Lausanne recommendations (including the use of 
14 European Journal of Cardiovascular Prevention and Rehabilitation 2006, Vol 13 No OO 
a 12-lead ECG), whereas the Bethesda Conference 
discussed the use of an ECG, but felt it was currently 
inappropriate to advise for use in the United States. 
Limitations of the study 
Severa! limitations in this study need to be specified. The 
definition of an athlete is very vague, without any 
quantitative values. Competition does not either have a 
quantitative definition. 
The most important limitation however is that SCD in 
young athletes as reported in the published and studied 
papers is certainly underestimated. Most of the events 
occur in youth potentially involved in sports activities, 
which are not reported in the literature. SCD is therefore 
likely to have comprised more than the 1101 athletes in 
the 38-year period across the world, which we reported. 
The Jack of national or international registers and the 
uncertainty of the number of athletes involved forms the 
basis of this problem. An effort to inventory ail cases of 
SCD in the future seems mandatory. 
A bias resides in the fact that some articles do not give 
the precise age of every case reported, but sometimes 
only an age range for the whole group considered. 
Certain sports are under-reported in the articles studied, 
such as cycling and rowing/canoeing. There are newer 
articles on cycling [101], which show significant numbers 
as reported to the smaller groups concerned. The 
International Cycling Union Cardiology Subcommission 
reports 14 competitive cyclists with major life-threaten-
ing cardiovascular problems. The athletes had trained and 
participated in competition for at least 5 years. They ail 
seem to have developed an acquired form of right 
ventricular electrical instability. 
Despite these limitations, this article tries to report facts 
and draw conclusions and cannot provide a final answer, 
but may provide a uniform format to help diminish this 
mortality. Further studies of efficacy are needed. 
Conclusion 
Sudden death in athletes is a serious problem that 
requires serious attention. The vast majority of these 
sudden deaths are caused by underlying cardiovascular 
diseases. Therefore, the general idea that most sudden 
deaths in sports are related to doping is contradicted by 
the large numbers of sudden deaths related to underlying 
cardiovascular diseases. 
The importance of the group of athletes suffering SCD 
under 18 or even 16 years of age is to be noted, and a 
serious screening should be offered to teenagers training 
and competing at a high level. 
Premature atherosclerosis in young athletes leads to 
death in a surprisingly large group of competitive 
athletes, when it was long thought to be a cause of death 
almost exclusively concerning aider athletes. 
The large variety of PPSP and the variability of persans 
using them prevent a serious evaluation of their efficacy. 
This evaluation would benefit from unified preparticipa-
tion recommendations, for which we propose the 
Lausanne Recommendations. 
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